Comparative study of mesenchymal stem cells from C57BL/10 and mdx mice by Li, Yong et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
BMC Cell Biology
Open Access Research article
Comparative study of mesenchymal stem cells from C57BL/10 and 
mdx mice
Yong Li2, Cheng Zhang*1,2, Fu Xiong2, Mei-juan Yu2, Fu-lin Peng1, Yan-
chang Shang1, Cui-ping Zhao1, Yong-feng Xu4, Zheng-shan Liu2, 
Chang Zhou1 and Jin-lang Wu3
Address: 1Department of Neurology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ProC, 2Stem Cells and Tissue 
Engineering Research Center, Sun Yat-Sen University, Guangzhou, Guangdong, ProC, 3Department of electron microscope, Sun Yat-Sen 
University, Guangzhou, Guangdong, ProC and 4Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, 
Hangzhou, ProC
Email: Yong Li - liyong999@yahoo.com; Cheng Zhang* - Zhangch6@mail.sysu.edu.cn; Fu Xiong - xf7803@yahoo.com.cn; Mei-
juan Yu - pxyspring@163.com; Fu-lin Peng - fulin706@21cn.com; Yan-chang Shang - yanchangshang@yahoo.com; Cui-
ping Zhao - zhaocuipingzsu@126.com; Yong-feng Xu - xuyongfeng925@163.com; Zheng-shan Liu - zhch0532@sina.com; 
Chang Zhou - niuzsss@sohu.com; Jin-lang Wu - lylovepxy@163.com
* Corresponding author    
Abstract
Background: Human mesenchymal stem cells (MSCs) have been studied and applied extensively
because of their ability to self-renew and differentiate into various cell types. Since most human
diseases models are murine, mouse MSCs should have been studied in detail. The mdx mouse – a
Duchenne muscular dystrophy model – was produced by introducing a point mutation in the
dystrophin gene. To understand the role of dystrophin in MSCs, we compared MSCs from mdx and
C57BL/10 mice, focusing particularly on the aspects of light and electron microscopic morphology,
immunophenotyping, and differentiation potential.
Results: Our study showed that at passage 10, mdx-MSCs exhibited increased heterochromatin,
larger vacuoles, and more lysosomes under electron microscopy compared to C57BL/10-MSCs.
C57BL/10-MSCs formed a few myotubes, while mdx-MSCs did not at the same passages. By
passage 21, mdx-MSCs but not C57BL/10-MSCs had gradually lost their proliferative ability. In
addition, a significant difference in the expression of CD34, not Sca-1 and CD11b, was observed
between the MSCs from the 2 mice.
Conclusion: Our current study reveals that the MSCs from the 2 mice, namely, C57BL/10 and
mdx, exhibit differences in proliferative and myogenic abilities. The results suggest that the changes
in mouse MSC behavior may be influenced by lack of dystrophin protein in mdx mouse.
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Background
Similar to hematopoietic stem cells, mesenchymal stem
cells (MSCs) are a type of stem cells derived from the bone
marrow (BM). They were identified by Cohnheim in 1867
and were described by Friedenstein and colleagues [1].
MSCs exhibit remarkable plasticity and harbor potential
for use in therapeutic applications, such as fibrosis [2],
cardiovasculogenesis treatments [3], arteriogenesis [4],
and immunosuppression [5]; they can also be used in tis-
sue engineering [6] and the correction of genetic disorders
[7].
As a research tool, MSCs offer the advantages of easy man-
ageability, versatility, and the ability to proliferate for pro-
longed periods without undergoing transformation [8].
The pleiotropic immune-related properties of MSCs (low
immunogenicity and lack of alloreactivity) have potential
for achieving haematopoietic stem ell transplantation
(HSCT) with a low incidence of GVHD (graft-versus-host
disease) [9,10]. In addition, the low cost of maintaining
mice and the detailed knowledge of mouse genetics [11]
favor the utilization of murine MSCs (mMSCs) for exten-
sive studies in the field of adult stem cell research.
Duchenne muscular dystrophy (DMD) is a common
recessive X-linked, monogenic muscular disorder with an
incidence of 1 in 3,500 male births. The primary genetic
defect leads to the near absence of dystrophin, resulting in
muscle damage and wasting. DMD boys experience pro-
gressive muscle wasting and weakness that becomes
apparent by 3–5 years of age and are wheelchair-bound by
12 years of age [12]. The research model that is most com-
monly employed for DMD is the mdx mouse. This mouse
has a point mutation in the 5'-end of its dystrophin gene
(exon 23) that creates a stop codon and an unstable trun-
cated protein and results in the complete loss of the full-
length dystrophin protein [13].
Many researchers have employed MSCs derived from dif-
ferent sources to enhance dystrophin expression and
ameliorate symptoms of mdx mice [14-18]. However, lit-
tle is known about the behavioral characteristics and func-
tions of mdx MSCs. Further, there is not much
information about the structural and ultrastructural dif-
ferences between mutant mouse mesenchymal stem cells
(mMSCs) (mdx mouse) and normal mMSCs (C57BL). In
this study, we investigated the differences in the morpho-
logical changes and colony-forming efficiency between
adult C57BL/10 and mdx MSCs by light and electron
microscopy; further, we investigated the behavioral differ-
ences between these 2 types of MSCs by flow cytometry.
Since the genetic  background of both the C57BL/10 and
mdx mice is very  similar [19], the absence of the dys-
trophin protein may result in a change in the features of
the mdx MSCs.
Methods
Isolation of stem cells and cell cultures
C57BL/10 adult mice were purchased from
NICPBP(National Institute for the Control of Pharmaceu-
tical and Biological Products)(Beijing, China), mdx
(C57BL/10ScSnJ) adult mice were purchased from The
Jackson Laboratory (Me, USA).
The local ethics committee approved the animal experi-
mentation protocols and all animal experiments were per-
formed according to Sun-Yet university guidelines for
animal care. MSCs were harvested from femur and tibia
bone marrow of C57BL/10 and mdx adult mice (6–8
weeks). The mice were housed in identical cages and
allowed access to water and a standard rodent diet shu
liang. All chemicals were purchased from Sigma (St.
Louis, MO) unless otherwise noted.
In brief, both C57BL/10 and mdx mouse were killed by
cervical dislocation and bone marrow was flushed out of
tibias and femurs with Dulbecco's modified Eagle's
medium (DMEM) containing 10% fetal bovine serum
(FBS) and 2 mM L-glutamine. After washing by centrifu-
gation at 400×g for 10 min and counting of viable trypan
blue-excluding cells in a Neubauer chamber, the cells were
resuspended with DMEM to a final concentration of
5×10^6 viable cells per millilitre. To initiate an mMSC
culture, cells were plated in six-well tissue culture dishes
(CELLSTAR, Greiner, German), at 2×10^6 cells/cm2. The
culture was kept in a humidified 5% CO2 incubator at
37°C for 72 h, non-adherent cells were removed by
changing the medium. When the adherent cells reached
confluence, covering 70%~80% of culture dish, the cells
were washed once with phosphate-buffered saline (PBS).
A 0.25% trypsin solution containing 0.01% ethylenedi-
aminetetraacetic acid (EDTA) incubated on monolayer at
37°C for 10 min. After detachment of the adherent cells
with a pipette, cells were resuspended in medium to a
final volume of 7 ml, and the resulting suspension was
split into two new wells. Subsequent passages were per-
formed similarly, except that incubation was for 5 min at
room temperature (RT) and split ratios were 1:2. After pas-
sage 4, the incubation with trypsin was less than 2 min.
and the split rate was set to 1:3. The culture medium was
changed every 3–4 days.
Light and electron microscopy
The mMSC cultures were routinely observed on an
inverted research microscope (Olympus, IX71, Japan).
Morphological analysis was carried out at P9 (53–63 days
of culture), P19 (88–98 days of culture), P25 (109–119
days of culture). Photomicrographs were taken with a
charge coupled device (CCD) camera (COOLSNAP-Procf,
Sony, Japan) coupled to an inverted microscope, using
Image-pro Express software.BMC Cell Biology 2008, 9:24 http://www.biomedcentral.com/1471-2121/9/24
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For electron microscopy, the medium was discarded from
the flask containing mMSCs, which were fixed in 1% para-
formaldehyde, 1.25% glutaraldehyde in 0.1 M PBS (pH
7.2) for 20 min. The cells were scraped from flask with cell
scraper, centrifuged at 800 g for 10 min and formed a cell
pellet in the bottom of centrifuge tube. The pellet was
then washed three times in 0.1 M PBS (pH 7.2), post-fixed
in 2% osmium tetroxide, dehydrated and embedded in
Epon812, which consists of dodecenylsuccinic anhydride
(23.5%), methyl nadic anhydride (72.5%), supplemented
with 4% of the accelerator DMP-30 (PELCO). The plasti-
cizer dibutyl phthalate was added at 0.5%. Thin sections
(50 nm) were cut on a LKB-I Ultracut UCT, stained with
uranyl acetate and lead citrate, and examined in a Hitachi-
600 transmission electron microscope (Japan). 65 mdx-
MSCs and 73 C57BL/10-MSCs were counted to assess
morphology in transmission electron microscope (TEM).
Colony forming units-fibroblast (CFU-F) assay
The CFU-F assay was performed using a modification of a
described protocol [20]. Cells cultured were resuspended
in the above medium to a concentration of 10 viable cells/
ml. Ten millilitre of this cell suspension was plated in a 10
cm Petri dish (1.7 cells/cm2).
The medium was changed 2 times per week. On the 13th
day, cultures were fixed and stained with Giemsa. Fibrob-
lastic colonies with more than 50 cells were counted
under an inverted microscope. Each mMSCs were per-
formed in triplicate in three C57BL/10 or mdx mice.
Flow cytometry
Cells were trypsinized, collected and incubated for 30 min
at 4°C with phycoerythrin (PE)- or fluorescein isothiocy-
anate (FITC)-conjugated antibodies against murine Sca-1
(stem cell antigen 1), CD11b, CD34 and IgG (Pharmin-
gen, USA). Excess antibody was removed by washing.
Detection of PE and FITC labeling was accomplished on a
FACScalibur cytometer (Becton Dickinson, San Jose, USA)
using CELLQuest software.
Differentiation of mMSCs
For osteogenesis, the cultures were incubated in DMEM
supplemented with 10% FBS, 2 mM L-glutamine, 10 mM
β-glycerol phosphate, 1 × 10-8 M dexamethasone, and 5
mg/L ascorbate 2-phosphate. The medium was changed 2
times per week for 3 weeks. The cells were fixed with 10%
formalin for 20 minutes at RT and stained with Alizarin
Red, pH 4.1 for 20 minutes at RT.
For adipogenesis, the cultures were incubated in DMEM
supplemented with 10% FBS, 2 mM L-glutamine, 5 µg/mL
insulin, 1 × 10-8 M dexamethasone. The medium was
changed 2 times per week for 3 weeks. The cells were fixed
with 10% formalin for 20 minutes at RT and stained with
0.5% Oil Red O in methanol for 20 minutes at RT.
For myogenesis, 5×10^3 cells/well were incubated in
DMEM supplemented with 10% FBS, 2 mM L-glutamine,
treated for 24 hours with 10 µmol/L 5-azacytidine in 10%
DMEM. 18 pieces of 6-well plates of C57BL/10-MSCs and
mdx-MSCs at passage 5, 10 and 13 were incubated over-
night in a 37°C incubator with a humidified atmosphere
of 5% CO2. The following day, the supernatant was
removed and replaced with 5% horse serum in DMEM
solution for 4 weeks. The medium was changed 2 times
per week. For the determination of MyHC (Myosin Heavy
Chain), and dystrophin, the cells were fixed with 4% para-
formaldehyde for 20 minutes at RT, followed by incuba-
tion with anti-MyHC-antibody (Santa Cruz
Biotechnology, Santa Cruz, CA) and anti-dystrophin
(Santa Cruz Biotechnology, Santa Cruz, CA). Secondary
antibodies were coupled with Cy3 (red) and used accord-
ing to the manufacturer's instructions. Nuclei were visual-
ized using a 30 µM 4',6'-diamidino-2-phenylindole
(blue).
Images were processed by an inverted research micro-
scope (Olympus, IX71, Japan). Digital images were ana-
lyzed using Image-pro Express software
RNA purification and gene expression analysis by RT-PCR 
after induction
After both MSCs were induced for three weeks, total cellu-
lar RNA was isolated using Trizol (Gibco-BRL, Life Tech-
nologies, MD). Random hexamer-primed reverse
transcription (MBI Fermentas Inc., Burlington, ON) was
performed on aliquots (1 ug) of total RNA as a template
and used the resultant cDNA for PCR amplification. Prim-
ers for osteocalcin (OCN), lipoprotein lipase (LPL), and
glyderaldehyde-3-phosphate dehydrogenase (GAPDH)
were synthesized based on the reported sequences. OCN
(199 bp): forward: 5'-TCTGACAAAGCCTTCATGTCC-3',
reverse: 5'-AAATAGTGATACCGTAGATGCG-3'; LPL (557
bp): forward: 5'-ACTCATCTCCGCCATGCC-3', reverse: 5'-
CCAGCTTTCTCCTAGCAAGG-3'; and GAPDH (203 bp):
forward: 5'-TGACCACAGTCCATGCCATC-3', reverse: 5'-
GACGGACACATTGGGGGTAG-3'. Reaction mixtures (30
ul) contained 1 ul cDNA, 30 pmol of each primer, 3 ul of
200 uM dNTP, and 1U Taq-DNA polymerase (MBI Fer-
mentas Inc., Burlington, ON). Amplification conditions
were as follows: 25 cycles of 94°C for 30 s; 55°C for 60 s;
and 72°C for 1 min, followed by a 72°C incubation for
10 min. The PCR products were detected by 1.2% agarose
gel electrophoresis and photographed.
Statistical analysis
Data are presented as mean ± standard deviation. A two-
sided, paired t test was used to analyze the flow cytometryBMC Cell Biology 2008, 9:24 http://www.biomedcentral.com/1471-2121/9/24
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and the isolation efficacy of CFU-F. Differences were con-
sidered significant at p < 0.05. The SPSS software package
(version 12.0) was used for the statistical tests.
Results
Morphology under light microscopy
BMs were isolated from 12 mice (C57BL/10 and mdx).
MSCs were isolated successfully from 8 mice – 5 C57BL/
10 and 3 mdx mice. The characteristics of 3 C57BL/10 and
3 mdx MSCs were examined.
The C57BL/10 and mdx mMSCs were generally observed
to be morphologically highly heterogeneous before pas-
sage 5 and comprised round, spindle-shaped, and flat-
tened cells (Fig. 1A, F). After passage 5, the morphology of
most cells was spindle-shaped, and few round cells were
observed (Fig. 1B–E, 1G–H). The population of spindle-
shaped mdx MSCs expanded gradually over time. These
cells ceased proliferating (Fig. 1I) before passage 25. How-
ever, the morphology of C57BL/10 MSCs was not altered
and these cells continued to proliferate even after passage
40 (Fig. 1E).
Morphology under TEM
At low magnification (Fig. 2A–C), the C57BL/10 and mdx
mMSCs at passage 10 appeared similar. They had a large
elliptical nucleus, with one or more nuclei located gener-
ally near the perinuclear cisternae (Fig. 2A–C). The chro-
matin was dispersed except for a thin dense layer located
immediately inside the perinuclear membrane (Fig. 2A–
G).
Phase contrast images of C57BL/10 MSCs (A-E) and mdx MSCs (F-I) Figure 1
Phase contrast images of C57BL/10 MSCs (A-E) and mdx MSCs (F-I). Passage 0 (A, F), passage 9 (B, G), passage 19 (C, H), pas-
sage 25 (D, I), and passage 40 (E). Round cells (A-I: thin black arrows). Spindle-shaped cells (A-I: arrowheads). Cells in Fig. G 
were more spindle-shaped than those in Fig. B. Cells in Fig. H to Fig. C showed the same result. Mesh and net formation was 
observed between the cells in Fig. I (pentagram). Scale bar, 200 µm.BMC Cell Biology 2008, 9:24 http://www.biomedcentral.com/1471-2121/9/24
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Ultrastructural observations indicated intact organelle
structure and ribosome-rich cytoplasm (Fig. 2D, G).
Rough endoplasmic reticulum and mitochondria were
detected in both the inner and peripheral endoplasmic
zones (Fig. 2C, G). The endoplasmic reticulum was often
observed to be expanded (Fig. 2D, E), giving the cyto-
plasm a small vacuolated appearance.
The morphological changes in 65 mdx MSCs at passage 10
and 13 under TEM were as follows: 3 (4.6%) cells exhib-
ited heterochromatin increase (Fig. 2C); 10 (15.4%), large
vacuoles (Fig. 2F, G); and 5 (7.7%), lysosomes (Fig. 2E–
G). No such changes were observed in the C57BL/10
MSCs at the same passage level.
The growth kinetics and population doubling time of both 
MSCs
Under the conditions defined in this study, cell conflu-
ence was usually reached between 10 and 14 d. The inter-
val between passages varied greatly until passage 5;
thereafter, a passage interval of approximately 4 d was set.
Continuous cell growth was observed in all cultures (Fig.
3A). In 5 C57BL/10 and 3 mdx MSCs, an increasing
growth rate was observed that stabilized after 45 d in cul-
ture; however, in some C57BL/10 MSCs, a constant
growth rate was observed till passage 40. The growth rate
of mdx MSCs appeared to decrease after passage 21
The doubling time of C57BL/10 MSCs in culture was ana-
lyzed at multiple time points over extended culture peri-
ods. In C57BL/10 MSCs, no significant changes were
observed between passages with regard to the time
required for population doubling (45 h–68 h). However,
the doubling time of mdx MSCs increased as the number
of passages increased (Fig. 3B). The mdx MSCs at passage
30 could not be analyzed as the doubling time became so
protracted that cells failed to reach this passage.
CFU-F assay
The ability of C57BL/10 and mdx MSCs to form fibroblas-
tic colonies was evaluated using a CFU-F assay. The
number of CFU-F/100 cells obtained at passage 15 is
Electron microscopic images of both C57BL/10 MSCs (A, B, D) and mdx MSCs (C, E, F, G) Figure 2
Electron microscopic images of both C57BL/10 MSCs (A, B, D) and mdx MSCs (C, E, F, G). All cells showed similar morpho-
logical features: an elliptical nucleus (N), usually with multiple nucleoli (pentagrams); various mitochondrial profiles; and small 
vacuoles (D, E: arrowheads). Big vacuoles (F, G: asterisks) and lysosomes (E-G: L) were observed in the cytoplasm of mdx 
MSCs, and heterochromatin was observed in the nucleus of these cells (C: thin white arrows). Chromatin formed a thin and 
dense layer inside the perinuclear cisternae (D-G: thin black arrows). Mitochondria (M) with both round and elongated profiles 
(D, G: thick white arrows) were observed. Scale bar, 1 µm.BMC Cell Biology 2008, 9:24 http://www.biomedcentral.com/1471-2121/9/24
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described in Additional tab. 1. Although the number of
CFU-F formed per 100 cells of C57BL/10 MSCs was higher
than that formed per 100 cells of mdx MSCs, the differ-
ence was not significant.
Flow cytometry
Flow cytometric analyses revealed changes in the morpho-
logical homogeneity of 3 C57BL/10 and 3 mdx MSCs at
passage 5, 9, and 19. A typical forward scatter (FSC-H) ×
side scatter (SSC-H) histogram (Fig. 4A–C) of C57BL/10
MSCs exhibited no distinct changes between the cells at
passages 5, 9, and 19. However, a similar histogram of
mdx MSCs indicated distinct changes in the morphology
of these cells. The mdx MSCs at passage 5 and 9 appeared
homogeneous (Fig. 4D, E) and those at passage 19 exhib-
ited 2 distinct populations (Fig. 4F, G).
The surface expression of molecular markers in mMSCs (3
C57BL/10 and 3 mdx) at passages 5, 9, and 19 was evalu-
ated (Fig. 4D–G). Both sets of cells were positive for Sca-1
and negative for CD11b, indicating that the mMSC popu-
lations were free of terminally differentiated hematopoi-
etic cells. The expression of CD34 differed between
C57BL/10 MSCs at different passage levels, whereas CD34
expression in mdx MSCs was always negative. There was a
significant difference in the expression of CD34 between
the 2 types of mMSCs, but no significant difference was
observed between these cell types with regard to the
expression of CD11b or Sca-1 (Additional tab. 1).
Differentiation assays
When cultured MSCs (3 C57BL/10 and 3 mdx) were
exposed to an osteoblast-induction medium, they formed
aggregates, and calcium deposits appeared after 3 weeks.
Alizarin red staining for calcium salt was performed. RT-
PCR analysis also showed that another osteogenic-specific
gene, namely, osteocalcin, was expressed in the cells after
osteogenic induction (Fig. 5). The ability to differentiate
into adipocytes was similar among MSCs derived from
both mice. Using RT-PCR, we also showed that these cells
expressed lipoprotein lipase, which is an adipocyte-asso-
ciated gene (Fig. 6).
Of the C57BL/10-MSCs in 54 wells including 9 negative
controls, MSCs at passages 5, 10, and 13 could form myo-
tubes (Fig. 7) in 9 wells (9/45); however, mdx MSCs at the
Growth kinetics and population doubling time of both MSCs Figure 3
Growth kinetics and population doubling time of both MSCs. The value 1 was substituted for the growth area (GA) occupied 
by a primary mMSC culture, which corresponded to 9.03 cm2, to simplify the calculation. When the second passage took place, 
the split ratio at passage 1 (1:3) was multiplied by this value, meaning that at the end of passage 1, the cumulative GA was 3 (i.e., 
3 times the growth area occupied by the primary culture). At the end of the second passage, the split ratio at passage 2 (1:2) 
was multiplied by the cumulative GA at passage 1 (3), resulting in a cumulative GA value of 6 at passage 2. This procedure was 
repeated for each passage, providing a theoretical growth curve that is directly proportional to the cell number. C57Bl/10: nor-
mal, male, 6–8 weeks old; mdx: male, 6–8 weeks old (A). A known number of MSC types from different passages were cul-
tured. The total cover area of cells in the flask was determined at different time points to obtain the doubling time. The values 
are expressed as means ± SD of 3 independent measurements (B).BMC Cell Biology 2008, 9:24 http://www.biomedcentral.com/1471-2121/9/24
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same passage levels did not, with most of the cells remain-
ing flat after myogenic induction.
Both C57/BL10 MSCs and mdx MSCs were repeatedly dif-
ferentiated individually 3 times and the similar results
were found.
Discussion
In both primary and passaged cultures of mMSCs, the
unwanted growth of nonmesenchymal cells is observed.
Therefore, the isolation of MSCs from mice is far more dif-
ficult than that from other species [21]. To resolve this
problem, we used an isolation technique that is consid-
ered to be specific for separating mMSCs [22-26]. Differ-
entiation assays showed that under appropriate culture
conditions, mMSCs of C57BL/10 and mdx origin could
differentiate into the adipocyte phenotype. This property
is presently considered to be a critical requirement in
identifying a putative MSC population [27,28]. However
in this study, with regard to the osteogenesis ability of
Immunophenotypic profile of both C57/BL10 and mdx MSCs Figure 4
Immunophenotypic profile of both C57/BL10 and mdx MSCs. Characteristic homogeneous FSC-H × SSC-H plot exhibited by 
5th passage C57BL/10 MSCs (A), 5th passage mdx MSCs (D), 9th passage C57BL/10 MSCs (B), 9th passage mdx MSCs (E), 19th 
passage C57BL/10 MSCs (C), and 19th passage mdx MSCs (F, G). Both types of mMSCs were incubated with antibodies against 
CD34, CD11b, and Sca-1 and assayed by FACS. Each antibody was tested individually, and representative plots from 3 samples 
from each strain are shown. Blue plot lines: negative control; red plot lines: MSCs.BMC Cell Biology 2008, 9:24 http://www.biomedcentral.com/1471-2121/9/24
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these mMSCs, the results of RT-PCR and alizarin red stain-
ing indicated that the osteogenesis ability of C57BL/10
MSCs was much greater than that of mdx MSCs (Fig. 5).
Further research is necessary to clarify this finding.
Immunophenotyping of both types of mMSCs at passages
5, 9, and 19 showed that CD11b, which is a marker for
granulocytes, monocytes, and natural killer cells, was
absent in mMSCs derived from both mice. In our culture
system, there was no need to sort CD11b-positive cells
from the medium [29,30]. In addition, both mMSCs at
different passage levels exhibited strong expression of Sca-
1.
CD34 is a very interesting stem cell marker. It is expressed
on the surface of HSCs, satellite cells, and endothelial pro-
genitors. Its pattern and level of expression in muscle stem
cells change as these cells differentiate into myotubes
[31]. It is not expressed on the surface of the MSCs of most
species [11,32]. However, some discrepancies were
observed between the findings of studies on CD34 expres-
sion on the surface of mMSCs [33-36]. In our study, sig-
nificant differences were observed between the 2 types of
mMSCs with regard to the expression of CD34 (p < 0.05).
This may result from differences in the niches of C57BL/
10 and mdx mMSCs. It can also be attributed to the differ-
ent behaviors of the 2 types of mMSCs. The mdx MSCs
lost their proliferative capability gradually at passage 21
and formed a mesh-like network (Fig. 1I), and most cells
decreased in size. These cells comprised a small popula-
tion (Fig. 4F–G) at passage 19 and showed increased het-
erochromatin (Fig. 2C). Human MSCs and other cells
show different morphological changes when they lose
their proliferative ability, and senescent cells are larger
and flatter than cells at other growth stages [37]. Com-
pared to the changes observed in mdx MSCs, C57BL/10
MSCs showed persistent proliferative capability and no
morphological changes over a period of 5 months.
Meirelles et al [23] showed that C57BL/10 cells main-
tained homogeneous characteristics over a period of 8
months [23]. The correlation between proliferative ability
and CD34 expression suggests that CD34+ cells may
Osteogenesis of both mMSCs Figure 5
Osteogenesis of both mMSCs. MSCs (3 C57BL/10 MSCs and 3 mdx MSCs) were induced in an osteogenic medium, and oste-
oblast differentiation was indicated by alizarin red staining. Negative control (A), C57BL/10 MSCs (B), and mdx-MSCs (C). The 
osteocalcin gene was detected in induced osteoblasts by RT-PCR. Lane 1-mdx MSCs, Lane 2-C57BL/10 MSCs, and Lane 3-neg-
ative control (D). Lane M, marker; GAPDH, glyderaldehyde-3-phosphate dehydrogenase; OCN, osteocalcin. Scale bar, 100 
µm.BMC Cell Biology 2008, 9:24 http://www.biomedcentral.com/1471-2121/9/24
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Adipogenesis of both mMSCs Figure 6
Adipogenesis of both mMSCs. MSCs (3 C57BL/10 MSCs and 3 mdx MSCs) were induced in an adipogenic medium. Adipogenic 
differentiation was indicated by oil red O staining. Negative control (A), C57BL/10 MSCs (B), and mdx MSCs (C). The expres-
sion of lipoprotein lipase was detected in induced adipocytes by RT-PCR. Lane 1-mdx MSCs, Lane 2-C57BL/10 MSCs, and Lane 
3-negative control (D). Lane M, marker; GAPDH, glyderaldehyde-3-phosphate dehydrogenase. Scale bar, 100 µm.
Myogenesis of C57BL/10 MSCs Figure 7
Myogenesis of C57BL/10 MSCs. Myotube formation in C57BL/10 MSCs at passage 13 (black arrows) (A, E), DAPI staining(B, F), 
MyHC (C) and dystrophin staining of a myotube (G), overlay of the MyHC (D) and dystrophin staining (H) (red fluorescence), 
DAPI staining (blue), and nucleoli (white arrows). Scale bar, 100 µm.BMC Cell Biology 2008, 9:24 http://www.biomedcentral.com/1471-2121/9/24
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divide many more times and proliferate to a greater extent
than CD34- cells [38,39]. In addition, although the col-
ony-forming efficiency of the 2 types of mMSCs in this
study was not significantly different, the colony-forming
efficiency of CD34+ MSCs was greater than that of CD34-
cells (Additional tab. 1). We found that C57BL/10 MSCs
(CD34+ MSCs) could form myotubes (Fig. 7A, E) under
suitable conditions [40], whereas mdx MSCs (CD34-
MSCs) did not do so under comparable conditions. This
also may be associated with differences between the 2
types of MSCs with regard to the expression of CD34 and
imply that CD34+ MSCs may exert a greater role in myo-
genesis than CD34- MSCs [31,41,42]. This finding also
suggested that CD34+ MSCs in the BM are one of the can-
didate cells involved in the formation of both myoblasts
and myofibers. [43].
Another explanation for the differences between the 2
types of mMSCs with regard to myogenesis is that the dys-
trophin protein may play a role in myotube maintenance.
The lack of dystrophin can lead to abnormal calcium
homeostasis [44] and elevated calpain proteolysis [45] in
the myotubes, resulting in a decrease in myotube forma-
tion.
There are only 5 published studies on the ultratructure of
MSCs [28,46-49]. These focus on the changes in normal
MSCs obtained after trypsinization. In our study, cells
were scraped from flasks; these cells might better reflect
the original cell state than cells treated with trypsin.
Two studies [48,49] showed that MSCs are "frequently
binucleate," but according to a study by Raimondo et al
[28], the 2 nuclei observed in MSCs can be attributed to
the irregular shape of the nucleus. Our findings suggested
that some binucleate mMSCs indeed existed (Fig. 2B).
Three observations supported this: first, the nuclei in the
MSCs were longer than those observed in other cells; sec-
ond, each nucleus had its own nucleolus; and third, the
space between the 2 nuclei was large.
Three studies [28,48,49] have reported the occurrence of
vacuoles in the cytoplasm of MSCs. According to Rai-
mondo et al [28], in most MSCs, vacuoles are formed as a
result of the dilatation of the endoplasmic reticulum and
Golgi apparatus. When the vacuoles in the C57BL/10 and
mdx mMSCs were compared, the existence of 2 types of
vacuoles was noted. The small vacuoles observed in both
mMSCs had arisen from the dilatation of the endoplasmic
reticulum and Golgi apparatus [28]. Large vacuoles were
mainly observed in mdx MSCs in addition to lysosomes.
They were formed as a result of cell degeneration, which
could be one of the reasons for the loss in the proliferative
ability of mdx MSCs.
In conclusion, our data showed that C57BL/10 MSCs
(CD34+ MSCs) exhibited stronger proliferative capability
and myogenic potential than mdx MSCs (CD34- MSCs).
dystrophin protein would play main role in the changes
of mouse MSC behavior.
Future research should be directed in 2 ways. First, the
relationship between dystrophin and myotube character-
istics such as myotube maintenance and myotube con-
traction should be determined; second, the proliferation
and in vivo delivery of CD34+ MSCs should be investi-
gated to clarify their potential application as therapeutic
agents in mdx mice.
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